Skip to content
S7767Senate2021-2022 SessionSame asA8697

Limit Drug List Changes

Official title

“Relates to prescription drug formulary changes during a contract year; repealer”

Sponsor Neil D. BreslinSD-44Affects Finance
Status
Signed by Governor
Impact
7/10
Significant
Outcome
Signed into law

Bill progress

Signed into law

What's happening

This bill prohibits insurers from making most prescription drug formulary changes during a plan year, with specific exceptions and notice requirements.

Why it matters

  1. Stabilizes Out-of-Pocket Costs. By prohibiting insurers from removing drugs or increasing cost-sharing for most medications mid-year, the bill helps consumers budget for their prescription expenses and reduces the risk of sudden, unaffordable price hikes during a coverage period.

  2. Protects Ongoing Treatments. Exceptions to formulary changes ensure that patients already taking a drug, or those with certain medical conditions, are not forced to switch therapies or pay more unexpectedly, supporting treatment continuity and medical stability.

  3. Enhances Transparency and Predictability. The requirement for insurers to provide 90 days’ advance notice of upcoming formulary or cost-sharing changes, both directly to enrollees and publicly online, empowers consumers to make informed decisions about their coverage before a new plan year starts.

  4. Maintains Flexibility for Safety and Generics. The bill allows mid-year changes only in specific cases, such as when the FDA determines a drug is unsafe or when a lower-cost generic or biosimilar is introduced, helping to balance patient protection with cost-containment and safety concerns.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

  • Patients with prescription drug coverage

    The bill would generally protect them from midyear drug removals, higher cost-sharing tiers and new utilization restrictions, subject to specified exceptions.

  • Health insurers and insurance corporations

    They would face limits on plan-year formulary changes and would have to give insureds 90 days’ notice of upcoming plan-year drug removals or cost-sharing changes, with notices also posted online.

  • Patients already taking a drug or with preexisting treatment needs

    They would be protected from the bill’s exception allowing certain midyear moves to higher-copayment tiers, though other exceptions could still apply.

  • Unions and labor representation groups

    The bill would preserve collective bargaining agreements and their rights to bargain over formulary changes.

Headline styles

Limit Drug List Changes

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Neil D. Breslin

Senator · Senate District 44

Chair, Insurance

No co-sponsors yet.

History

  1. Signed chap.99
  2. Delivered to governor
  3. Returned to senate
  4. Passed assembly
  5. Ordered to third reading cal.301
  6. Substituted for A8697
  7. Referred to insurance
  8. Delivered to assembly
  9. Passed senateVote 53–9
  10. Ordered to third reading cal.140
  11. Referred to rules

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A8697Assembly

Limit Midyear Drug Changes

Assembly Floor Calendar · Sponsor Crystal Peoples-Stokes

Impact 7 · Significant0% to pass

Full text

3 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

7767

IN SENATE

January 11, 2022

Introduced by Sen. BRESLIN -- read twice and ordered printed, and when printed to be committed to the Committee on Rules

AN ACT to amend the insurance law, in relation to prescription drug formulary changes during a plan year; to amend a chapter of the laws of 2021 amending the insurance law and the public health law relating to prescription drug formulary changes during a contract year, as proposed in legislative bills numbers S. 4111 and A. 4668, in relation to the effectiveness thereof; and to repeal section 4909 of the insurance law and section 4909 of the public health law relating thereto

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Section 4909 of the insurance law, as added by a chapter of the laws of 2021 amending the insurance law and the public health law relating to prescription drug formulary changes during a contract year, as proposed in legislative bills numbers S. 4111 and A. 4668, is REPEALED.

§ 2. Section 4909 of the public health law, as added by a chapter of the laws of 2021 amending the insurance law and the public health law relating to prescription drug formulary changes during a contract year, as proposed in legislative bills numbers S. 4111 and A. 4668, is REPEALED.

§ 3. Section 3242 of the insurance law is amended by adding a new subsection (c) to read as follows:

(c)(1) Except as otherwise provided in paragraph three of this subsection, an insurer shall not:

(A) remove a prescription drug from a formulary;

(B) move a prescription drug to a tier with a larger deductible, copayment, or coinsurance if the formulary includes two or more tiers of benefits providing for different deductibles, copayments or coinsurance applicable to the prescription drugs in each tier; or

(C) add utilization management restrictions to a prescription drug on a formulary, unless such changes occur at the time of enrollment, issuance or renewal of coverage.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD08236-02-2

(2) Prohibitions provided in paragraph one of this subsection shall apply beginning on the date on which a plan year begins and through the end of such plan year.

(3) (A) An insurer with a formulary that includes two or more tiers of benefits providing for different deductibles, copayments or coinsurance applicable to prescription drugs in each tier may move a prescription drug to a tier with a larger deductible, copayment or coinsurance if an AB-rated generic equivalent or interchangeable biological product for such prescription drug is added to the formulary at the same time.

(B) An insurer may remove a prescription drug from a formulary if the federal Food and Drug Administration determines that such prescription drug should be removed from the market, including new utilization management restrictions issued pursuant to federal Food and Drug Administration safety concerns.

(C) An insurer with a formulary that includes two or more tiers of benefits providing for different copayments applicable to prescription drugs may move a prescription drug to a tier with a larger copayment during the plan year, provided the change is not applicable to an insured who is already receiving such prescription drug or has been diagnosed with or presented with a condition on or prior to the start of the plan year that is treated by such prescription drug or is a prescription drug that is or would be part of the insured's treatment regimen for such condition.

(4) An insurer shall provide notice to insureds of the intent to remove a prescription drug from a formulary or alter deductible, copayment or coinsurance requirements in the upcoming plan year, ninety days prior to the start of the plan year. Such notice of impending formulary and deductible, copayment or coinsurance changes shall also be posted on the insurer's online formulary and in any prescription drug finder system that the insurer provides to the public.

(5) The provisions of this subsection shall not supersede the terms of a collective bargaining agreement, or the rights of labor representation groups to collectively bargain changes to the formularies.

§ 4. Section 4329 of the insurance law is amended by adding a new subsection (c) to read as follows:

(c) (1) Except as otherwise provided in paragraph three of this subsection, a corporation shall not:

(A) remove a prescription drug from a formulary;

(B) move a prescription drug to a tier with a larger deductible, copayment, or coinsurance if the formulary includes two or more tiers of benefits providing for different deductibles, copayments or coinsurance applicable to the prescription drugs in each tier; or

(C) add utilization management restrictions to a prescription drug on a formulary, unless such changes occur at the time of enrollment, issuance or renewal of coverage.

(2) Prohibitions provided in paragraph one of this subsection shall apply beginning on the date on which a plan year begins and through the end of such plan year.

(3) (A) A corporation with a formulary that includes two or more tiers of benefits providing for different deductibles, copayments or coinsurance applicable to prescription drugs in each tier may move a prescription drug to a tier with a larger deductible, copayment or coinsurance if an AB-rated generic equivalent or interchangeable biological product for such prescription drug is added to the formulary at the same time.

(B) A corporation may remove a prescription drug from a formulary if the federal Food and Drug Administration determines that such prescription drug should be removed from the market, including new utilization management restrictions issued pursuant to federal Food and Drug Administration safety concerns.

(C) A corporation with a formulary that includes two or more tiers of benefits providing for different copayments applicable to prescription drugs may move a prescription drug to a tier with a larger copayment during the plan year, provided the change is not applicable to an insured who is already receiving such prescription drug or has been diagnosed with or presented with a condition on or prior to the start of the plan year that is treated by such prescription drug or is a prescription drug that is or would be part of the insured's treatment regimen for such condition.

(4) A corporation shall provide notice to insureds of the intent to remove a prescription drug from a formulary or alter deductible, copayment or coinsurance requirements in the upcoming plan year, ninety days prior to the start of the plan year. Such notice of impending formulary and deductible, copayment or coinsurance changes shall also be posted on the corporation's online formulary and in any prescription drug finder system that the corporation provides to the public.

(5) The provisions of this subsection shall not supersede the terms of a collective bargaining agreement, or the rights of labor representation groups to collectively bargain changes to the formularies.

§ 5. Section 3 of a chapter of the laws of 2021 amending the insurance law and the public health law relating to prescription drug formulary changes during a contract year, as proposed in legislative bills numbers S. 4111 and A. 4668, is amended to read as follows:

§ 3. This act shall take effect on [the sixtieth day after it shall have become a law] January 1, 2023 and shall apply to all policies and contracts issued, renewed, modified, altered or amended on or after such date. Effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the [implantation] implementation of this act on its effective date are authorized to be made on or before such effective date.

§ 6. This act shall take effect immediately; provided, however, that sections one, two, three and four of this act shall take effect on the same date and in the same manner as a chapter of the laws of 2021 amending the insurance law and the public health law relating to prescription drug formulary changes during a contract year, as proposed in legislative bills numbers S. 4111 and A. 4668, takes effect.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the insurance law, in relation to prescription drug formulary changes during a plan year; to amend a chapter of the laws of 2021 amending the insurance law and the public health law relating to prescription drug formulary changes during a contract year, as proposed in legislative bills numbers S. 4111 and A. 4668, in relation to the effectiveness thereof; and to repeal section 4909 of the insurance law and section 4909 of the public health law relating thereto

Purpose

This is a chapter amendment that makes changes to provisions of L.2021, c.780.

Summary of provisions

The underlying chapter prohibits prescription drug formulary changes during a contract year, except under limited circumstances. This chapter amendment makes technical changes to the underlying chapter. Also, it changes language to prohibit formulary changes from the "date a plan year begins" instead of barring modifications from the "open enrollment date." In addition, it expands the timeframe for the notice of intent to make changes from the original 30 days before open enrollment to 90 days before the start of the plan year. Finally, it changes the underlying chapter amendment's effective date to January 1, 2023.

Existing law

None.

Justification

This legislation is a negotiated change to the underlying chapter to capture plans that start coverage outside of the regular January cycle and to give time for implementation.

Legislative history

Chapter amendment to Chapter 780 of the Laws of 2021. S.4111 and A.4668 both passed the Senate and Assembly, respectfully, in May 2021.

Fiscal implications

None.

Effective date

This act shall take effect immediately; provided, however, that sections one, two, three and four of this act shall take effect on the same date and in the same manner as a chapter of the laws of 2021 amending the insurance law and the public health law relating to prescription drug formulary changes during a contract year, as proposed in legislative bills numbers S.4111 and A.4668, takes effect.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.